Acid-active supramolecular anticancer nanoparticles based on cyclodextrin polyrotaxanes damaging both mitochondria and nuclei of tumor cells
Author:
Affiliation:
1. Institute for Clean Energy and Advanced Materials
2. Faculty of Materials and Energy
3. Southwest University
4. Chongqing 400715
5. P. R. China
6. Department of Hematology and Oncology
7. Shenzhen Children's Hospital
8. Shenzhen
9. P.R. China
Abstract
Acid-active supramolecular theranostics based on cyclodextrin polyrotaxanes for enhanced cancer therapy.
Funder
National Natural Science Foundation of China
Southwest University
China Postdoctoral Science Foundation
Chongqing Postdoctoral Science Special Foundation
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering
Link
http://pubs.rsc.org/en/content/articlepdf/2018/BM/C8BM01020J
Reference50 articles.
1. Therapeutic strategies to improve drug delivery across the blood-brain barrier
2. The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
3. In Vitro and in Vivo Studies on the Transport of PEGylated Silica Nanoparticles across the Blood–Brain Barrier
4. In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood–Brain Barrier
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polymeric Micelles as Drug Delivery System: Recent Advances, Approaches, Applications and Patents;Current Drug Safety;2024-05
2. Recent advances in nanocarriers for clinical platinum(II) anticancer drugs;Coordination Chemistry Reviews;2024-04
3. Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review;Frontiers in Oncology;2023-06-22
4. Slide‐Ring Materials Based on Self‐assembled Polyrotaxane “Molecular Necklaces”;Supramolecular Nanotechnology;2023-04-21
5. Cyclodextrin-Based Arsenal for Anti-Cancer Treatments;Critical Reviews™ in Therapeutic Drug Carrier Systems;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3